Back to Companies
Alkermes plc.
ALKSNasdaqCIK: 0001520262
Recent Form 4 activity at Alkermes plc. (ALKS) spans 50 filings across 15 insiders (all of them on the sell side). Purchases total $0 against $9.8M in sales — heavily weighted toward selling, for net sales of $9.8M. Jackson Blair Curtis (President & CEO, Alkermes plc, Director) is the most active by dollar volume, and the single largest transaction was $10.8M by Jackson Blair Curtis. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$49.5M
Purchases
$0
Sales
$9.8M
Unique Insiders
15
Recent Insider Trades
50 loaded
| Sep 3 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $97.7K |
| Sep 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $422.9K |
| Aug 17 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | $372.9K |
| Aug 7 | ALKS Alkermes plc. | Jackson Blair Curtis | President & CEO, Alkermes plc, Director | Award | $10.8M |
| Aug 3 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $437.2K |
| Aug 3 | ALKS Alkermes plc. | snyderman nancy lynn MD | Director | Sell | $2.2M |
| Aug 3 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $98.8K |
| Jul 6 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $109.9K |
| Jul 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $463.6K |
| Jun 4 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $87.6K |
| Jun 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $375.0K |
| May 29 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | $687.0K |
| May 22 | ALKS Alkermes plc. | snyderman nancy lynn MD | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | GAYNOR RICHARD | Director | Award | $426.7K |
| May 22 | ALKS Alkermes plc. | Cooke Shane | Director | Exercise | $545.2K |
| May 22 | ALKS Alkermes plc. | Wright Christopher I | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Cooke Shane | Director | Award | $426.7K |
| May 22 | ALKS Alkermes plc. | GAYNOR RICHARD | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | MCKEON BRIAN P | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | LAURENCIN CATO T | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Lurker Nancy | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Wilson Frank Anders | Director | Exercise | $481.2K |
| May 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $300.6K |
| Apr 13 | ALKS Alkermes plc. | Lurker Nancy | Director | Exercise | $30.1K |
| Apr 6 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $70.3K |
| Apr 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $319.6K |
| Mar 4 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | $180.0K |
| Mar 4 | ALKS Alkermes plc. | Reed Joshua | SVP, Chief Financial Officer | Award | $2.0M |
| Mar 4 | ALKS Alkermes plc. | POPS RICHARD F | Director and CEO, Alkermes plc, Director | Award | $0 |
| Mar 4 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | $201.8K |
| Mar 4 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Award | $2.9M |
| Mar 4 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $120.1K |
| Mar 4 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $267.5K |
| Feb 27 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $24.8K |
| Feb 27 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Exercise | $73.8K |
| Feb 25 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Exercise | $109.9K |
| Feb 25 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $21.6K |
| Feb 25 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Exercise | $124.9K |
| Feb 25 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Exercise | $109.9K |
| Feb 25 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Exercise | $91.6K |
| Feb 20 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Exercise | $253.7K |
| Feb 20 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $53.9K |
| Feb 20 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Exercise | $177.1K |
| Feb 20 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Exercise | $221.2K |
| Feb 2 | ALKS Alkermes plc. | Cooke Shane | Director | Sell | $2.1M |
| Feb 2 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $305.4K |
| Jan 8 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $150.0K |
| Jan 2 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $112.0K |
| Dec 5 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $112.4K |
| Dec 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $117.2K |
50 filings+